20250827-交银国际证券-第四范式-06682.HK-传统行业AI生产力需求提振收入，2025年扭亏为盈目标不变；上调目标价.pdf 20250828-招银国际-中国平安-02318.HK-1H25 a mixed bag: NBV beat while OPAT in line.pdf 20250828-招银国际-华润万象生活-01209.HK-1H25: Robust core biz growth with 100% dividend payout; Maintain Buy.pdf 20250828-招银国际-美团-W-03690.HK-Seeking efficient ways to respond to intense competition.pdf 20250828-招银国际-美东汽车-01268.HK-Resilient profit, cash flow; Porsche to bottom out？.pdf 20250828-国盛证券-申洲国际-02313.HK-2025H1收入增长超预期，核心客户份额提升.pdf 20250827-交银国际证券-康方生物-09926.HK-依沃西达到首个OS终点，医保覆盖推动商业化版图扩张；上调目标价.pdf 20250821-招银国际-2Q25 review: core membership and advertising businesses to recover in 3Q25.pdf 20250822-招银国际-讯飞医疗科技-02506.HK-Government remains the primary driving force of medical AI applications.pdf 20250822-招银国际-途虎-W-09690.HK-Market share gain on superb management.pdf